Novo Nordisk Stock Climbs on Report Parvus Asset Taking Stake

June 10, 2025 05:12 AM PDT | By EODHD
 Novo Nordisk Stock Climbs on Report Parvus Asset Taking Stake
Image source: Kalkine Media
June 10 - Novo Nordisk (NYSE:NVO) rose to its highest level in over two months Monday after a media report said hedge fund Parvus Asset Management is quietly building a position in the Danish pharmaceutical group. Shares advanced as much as 3%. Warning! GuruFocus has detected 1 Warning Sign with NVO. Parvus is reportedly aiming to influence the company's upcoming leadership transition. Novo Nordisk said in an email that it has nothing to share on this topic.

The report follows last month's news that CEO Lars Fruergaard Jorgensen will step down. His departure comes after the company's stock fell sharply from record highs seen in mid-2023. Novo is under mounting pressure in the weight-loss drug market, where Eli Lilly (NYSE:LLY) has made competitive gains. Analysts have pointed to slowing momentum in Novo's drug pipeline, raising questions about long-term growth. Parvus, known for prior activist campaigns at Ryanair and UniCredit, did not disclose how much of Novo it currently owns.

This article first appeared on GuruFocus. View Comments

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next